Global Carbapenem Based Antibiotics Market Report 2024

Carbapenem-Based Antibiotics Global Market Report 2024 – By Type (Meropenem, Imipenem, Doripenem, Tebipenem, Other Types), By Indication (Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin and Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Carbapenem-Based Antibiotics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Carbapenem-Based Antibiotics Market Definition And Segments

Carbapenem-based antibiotics are a class of broad-spectrum antibiotics that are highly effective against many bacterial infections. Carbapenem antibiotics are commonly used to treat severe infections caused by gram-positive and gram-negative bacteria, including some strains resistant to other antibiotics.

The main types of carbapenem-based antibiotics are meropenem, imipenem, doripenem, tebipenem, and others. Meropenem is a broad-spectrum antibiotic used to treat a wide range of bacterial infections by inhibiting bacterial cell wall synthesis. Meropenem is used to treat a variety of serious bacterial infections, including pneumonia, meningitis, intra-abdominal infections, urinary tract infections, and skin and soft tissue infections. The carbapenem-based antibiotics are used to treat intra-abdominal infections, urinary tract infections, pneumonia, bacterial meningitis, skin and skin structure infections, acute pelvic infections, prophylaxis of surgical site infection, respiratory tract infections, gynecologic infections, and others that are sold in hospital pharmacies, retail pharmacies, and online pharmacies.

The carbapenem-based antibiotics market covered in this report is segmented –

1) By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types

2) By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin and Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The carbapenem-based antibiotics market size has grown strongly in recent years. It will grow from $4.43 billion in 2023 to $4.66 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epidemics and pandemics, rise in chronic diseases, healthcare infrastructure growth, rapid urbanization, natural disasters and health emergencies.

The carbapenem-based antibiotics market size is expected to see strong growth in the next few years. It will grow to $5.71 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increased incidence of hospital-acquired infections, emergence of multi-drug resistant strains, growing aging population, rise in surgical procedures, proliferation of infectious diseases, changing demographics. Major trends in the forecast period include supply chain resilience and security, alternative treatment development, shift towards outpatient settings, growing awareness on antimicrobial stewardship, precision medicine approaches.

Rising Bacterial Infections And The Surge In Demand For Carbapenem-Based Antibiotics Is A Driving Force In Market Expansion

The increasing incidence of bacterial infections is expected to propel the growth of the carbapenem-based antibiotics market going forward. Bacterial infections are infections caused by bacteria, microscopic organisms that can invade the body and cause a range of diseases and symptoms. Carbapenem-based antibiotics treat severe or multidrug-resistant bacterial infections, including those caused by gram-positive and gram-negative bacteria. For Instance, In November 2022, according to the report published by the UK Health Security Agency (UKHSA), an executive government agency of the Department of Health and Social Care, in England, the anticipated total number of antibiotic-resistant severe infections increased by 2.2% in 2021. Therefore, an increased incidence of bacterial infections drives the growth of the carbapenem-based antibiotics market.

Surge In Surgical Procedures Fuels Growth Of The Carbapenem-Based Antibiotics Market

The increasing number of surgical procedures is expected to propel the growth of the carbapenem-based antibiotics market going forward. Surgical procedures refer to medical interventions performed by a qualified surgeon to treat, repair, remove, or replace a part of the body that may be affected by disease, or injury. Carbapenems offer a broad spectrum of activity, effective against infections in the abdominal cavity, combat infections, reduce the need for combination therapy, simplifying treatment regimens in surgical patients, and effective in the treatment of meningitis. For instance, in June 2022, according to the American Society for Metabolic and Bariatric Surgery (ASMBS), a US-based non-profit medical organization, in 2021, approximately 262,893 bariatric surgeries were conducted. Therefore, the increasing number of surgical procedures is driving the growth of the carbapenem-based antibiotics market.

Major companies operating in the carbapenem-based antibiotics market report are Pfizer Inc., Merck & Co. Inc., Saint-Gobain S.A., Fresenius Kabi LLC, GlaxoSmithKline PLC, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Meiji Holdings Co. Ltd., Sandoz International GmbH, Sumitomo Dainippon Pharma Co. Ltd., Shionogi & Co Ltd., Aurobindo Pharma Ltd., Acurx Pharmaceuticals LLC, Daewoong Pharmaceutical Co. Ltd., CeramTec GmbH, ACS Dobfar S.p.A, JW Pharmaceutical Corp, Centrient Pharmaceuticals Co, Spero Therapeutics Inc., Kopran Limited, Savior Lifetec Corporation, Amedica Corporation, Flagship Biotech International Pvt. Ltd., Iterum Therapeutics PLC, Cam Carbapenem-based antibiotics BV, Intelicure Lifesciences, Ikeda Corporation

Innovative Product Launches Drive Growth In The Carbapenem-Based Antibiotics Market

Product Innovations are the key trend gaining popularity in the carbapenem-based antibiotics market. Major companies operating in the carbapenem-based antibiotics market are innovating products to sustain their position in the market. For instance, in September 2021, BDR Pharmaceuticals International Pvt. Ltd. an India-based pharmaceutical company launched biapenem. Biapenem is administered to individuals suffering from lower respiratory infections, complex urinary tract infections, or intra-abdominal infections. Biapenem has demonstrated clinical and bacteriological efficacy that is comparable to imipenem/cilastatin in treating patients with these kinds of illnesses.

Pfizer's Investment In Spero Therapeutics Boosts Global Expansion Of Carbapenem-Based Antibiotics

Major companies operating in the carbapenem-based antibiotics market are focusing on investments to drive revenues in their market. For instance, in June 2021, Pfizer Inc. a US-based pharmaceutical and biotechnology corporation invested $40 million in Spero Therapeutics Inc. Spero has given Pfizer permission to create, produce, and market SPR206 outside of the United States and Asia. It is anticipated that this financing and license arrangement would support the ongoing clinical development of SPR720 and SPR206, giving Spero significant financial flexibility and capital. Pfizer's investment in Spero is in line with its goal to encourage cutting-edge research and satisfy patient demands. It also gives Spero the capital it needs to progress clinical development and increase product accessibility internationally. Spero Therapeutics Inc. is a US-based biopharmaceutical company focused on developing novel therapies to treat bacterial infections.

GSK PLC Secures Exclusive License For Tebipenem HBR From Spero Therapeutics Inc.

In September 2022, GSK PLC, a UK-based pharmaceutical and biotechnology company, and Spero Therapeutics, Inc. entered into an exclusive license agreement for $66 million upfront, with the potential for future milestone payments and tiered royalties. The exclusive license allows GSK to commercialize tebipenem HBr in all regions except for Japan and certain other Asian countries. Spero Therapeutics is a US-based clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments and medicine for bacterial infections, including multi-drug resistant and rare diseases, including carbapenem oral antibiotic.

North America was the largest region in the Carbapenem-Based Antibiotics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the carbapenem-based antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the carbapenem-based antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The carbapenem-based antibiotics market consists of sales of imipenem-cilastatin, meropenem, ertapenem, doripenem, biapenem, panipenem, tebipenem, razupenem, tomopenem, and faropenem. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The carbapenem-based antibiotics market research report is one of a series of new reports from The Business Research Company that provides carbapenem-based antibiotics market statistics, including the carbapenem-based antibiotics industry's global market size, regional shares, competitors with a carbapenem-based antibiotics market share, detailed carbapenem-based antibiotics market segments, market trends, and opportunities, and any further data you may need to thrive in the carbapenem-based antibiotics industry. This carbapenem-based antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Carbapenem-Based Antibiotics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $4.66 billion
Revenue Forecast In 2033 $5.71 billion
Growth Rate CAGR of 5.2% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types
2) By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin and Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Merck & Co. Inc.; Saint-Gobain S.A.; Fresenius Kabi LLC; GlaxoSmithKline Plc; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; AstraZeneca plc; Meiji Holdings Co. Ltd.; Sandoz International GmbH; Sumitomo Dainippon Pharma Co. Ltd.; Shionogi & Co Ltd.; Aurobindo Pharma Ltd.; Acurx Pharmaceuticals LLC; Daewoong Pharmaceutical Co. Ltd.; CeramTec GmbH; ACS Dobfar S.p.A; JW Pharmaceutical Corp; Centrient Pharmaceuticals Co; Spero Therapeutics Inc.; Kopran Limited; Savior Lifetec Corporation; Amedica Corporation; Flagship Biotech International Pvt. Ltd.; Iterum Therapeutics plc; Cam Carbapenem-based antibiotics BV; Intelicure Lifesciences; Ikeda Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Carbapenem-Based Antibiotics Market Characteristics

    3. Carbapenem-Based Antibiotics Market Trends And Strategies

    4. Carbapenem-Based Antibiotics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Carbapenem-Based Antibiotics Market Size and Growth

    5.1. Global Carbapenem-Based Antibiotics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Carbapenem-Based Antibiotics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Carbapenem-Based Antibiotics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Carbapenem-Based Antibiotics Market Segmentation

    6.1. Global Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Meropenem

    Imipenem

    Doripenem

    Tebipenem

    Other Types

    6.2. Global Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Intra-abdominal Infections

    Urinary Tract Infections

    Pneumonia

    Bacterial Meningitis

    Skin and Skin Structure Infections

    Acute Pelvic Infections

    Prophylaxis of Surgical Site Infection

    Respiratory Tract Infections

    Gynecological Infections

    Other Indications

    6.3. Global Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. Carbapenem-Based Antibiotics Market Regional And Country Analysis

    7.1. Global Carbapenem-Based Antibiotics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Carbapenem-Based Antibiotics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Carbapenem-Based Antibiotics Market

    8.1. Asia-Pacific Carbapenem-Based Antibiotics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Carbapenem-Based Antibiotics Market

    9.1. China Carbapenem-Based Antibiotics Market Overview

    9.2. China Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Carbapenem-Based Antibiotics Market

    10.1. India Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Carbapenem-Based Antibiotics Market

    11.1. Japan Carbapenem-Based Antibiotics Market Overview

    11.2. Japan Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Carbapenem-Based Antibiotics Market

    12.1. Australia Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Carbapenem-Based Antibiotics Market

    13.1. Indonesia Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Carbapenem-Based Antibiotics Market

    14.1. South Korea Carbapenem-Based Antibiotics Market Overview

    14.2. South Korea Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Carbapenem-Based Antibiotics Market

    15.1. Western Europe Carbapenem-Based Antibiotics Market Overview

    15.2. Western Europe Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Carbapenem-Based Antibiotics Market

    16.1. UK Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Carbapenem-Based Antibiotics Market

    17.1. Germany Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Carbapenem-Based Antibiotics Market

    18.5. France Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Carbapenem-Based Antibiotics Market

    19.9. Italy Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Carbapenem-Based Antibiotics Market

    20.13. Spain Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Carbapenem-Based Antibiotics Market

    21.1. Eastern Europe Carbapenem-Based Antibiotics Market Overview

    21.2. Eastern Europe Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Carbapenem-Based Antibiotics Market

    22.1. Russia Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Carbapenem-Based Antibiotics Market

    23.1. North America Carbapenem-Based Antibiotics Market Overview

    23.2. North America Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Carbapenem-Based Antibiotics Market

    24.1. USA Carbapenem-Based Antibiotics Market Overview

    24.2. USA Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Carbapenem-Based Antibiotics Market

    25.1. Canada Carbapenem-Based Antibiotics Market Overview

    25.2. Canada Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Carbapenem-Based Antibiotics Market

    26.1. South America Carbapenem-Based Antibiotics Market Overview

    26.2. South America Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Carbapenem-Based Antibiotics Market

    27.1. Brazil Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Carbapenem-Based Antibiotics Market

    28.1. Middle East Carbapenem-Based Antibiotics Market Overview

    28.2. Middle East Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Carbapenem-Based Antibiotics Market

    29.1. Africa Carbapenem-Based Antibiotics Market Overview

    29.2. Africa Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Carbapenem-Based Antibiotics Market Competitive Landscape And Company Profiles

    30.1. Carbapenem-Based Antibiotics Market Competitive Landscape

    30.2. Carbapenem-Based Antibiotics Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Merck & Co. Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Saint-Gobain S.A.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Fresenius Kabi LLC

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. GlaxoSmithKline Plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Carbapenem-Based Antibiotics Market Other Major And Innovative Companies

    31.1. Eli Lilly and Company

    31.2. Teva Pharmaceutical Industries Ltd.

    31.3. AstraZeneca plc

    31.4. Meiji Holdings Co. Ltd.

    31.5. Sandoz International GmbH

    31.6. Sumitomo Dainippon Pharma Co. Ltd.

    31.7. Shionogi & Co Ltd.

    31.8. Aurobindo Pharma Ltd.

    31.9. Acurx Pharmaceuticals, LLC

    31.10. Daewoong Pharmaceutical Co. Ltd.

    31.11. CeramTec GmbH

    31.12. ACS Dobfar S.p.A

    31.13. JW Pharmaceutical Corp

    31.14. Centrient Pharmaceuticals Co

    31.15. Spero Therapeutics Inc.

    32. Global Carbapenem-Based Antibiotics Market Competitive Benchmarking

    33. Global Carbapenem-Based Antibiotics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Carbapenem-Based Antibiotics Market

    35. Carbapenem-Based Antibiotics Market Future Outlook and Potential Analysis

    35.1 Carbapenem-Based Antibiotics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Carbapenem-Based Antibiotics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Carbapenem-Based Antibiotics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Carbapenem-Based Antibiotics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Carbapenem-Based Antibiotics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Merck & Co. Inc. Financial Performance
  • Table 76: Saint-Gobain S.A. Financial Performance
  • Table 77: Fresenius Kabi LLC Financial Performance
  • Table 78: GlaxoSmithKline Plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Carbapenem-Based Antibiotics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Carbapenem-Based Antibiotics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Merck & Co. Inc. Financial Performance
  • Figure 76: Saint-Gobain S.A. Financial Performance
  • Figure 77: Fresenius Kabi LLC Financial Performance
  • Figure 78: GlaxoSmithKline Plc Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Automobile Rental And Leasing Market - By Type (Passenger Car Rental , Passenger Car Leasing, Truck, Utility Trailer, And Recreational Vehicle Rental And Leasing), By Type Of Mode (Offline, Online), By Type Of Lease (Open, Close), By End User (Individual, Corporate), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Automotive Repair and Maintenance Global Market Report 2024 – By Type (Automotive Mechanical And Electrical Repair And Maintenance, Automotive Body, Paint, Interior, And Glass Repair, Other Automotive Repair And Maintenance), By Vehicle Type (Passenger Cars, Light Commercial Vehicles, Heavy Commercial Vehicles, Bike And Scooter), By Service Provider (Automotive Dealership, Franchise General Repair, Specialty Shop, Locally Owned Repair Shops/Body Shop, Others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Automotive Halogen Bulbs Global Market Report 2024 – By Product (Halogen Short-Arc Lights, Halogen Long-Arc Lights, Halogen Flash Lights), By Vehicle Type (Passenger Vehicle, Commercial Vehicle), By Application (OEMs, Aftermarket) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Automotive Light Emitting Diode (LED) Bulbs Global Market Report 2024 – By Vehicle Type (Passenger Car, Light Commercial Vehicle (LCV), Heavy Commercial Vehicle (HCV)), By Adaptive Lighting (Front Adaptive Lighting, Rear Adaptive Lighting, Ambient Adaptive Lighting), By Sales Channel (OEM, Aftermarket) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Automotive Cables Global Market Report 2024 – By Product Type (Copper Core, Aluminum Core, Other Product Types), By Sales Channel (Direct Channel, Distribution Channel), By Application (Automotive Primary Wire and Battery Cable, Brake Cable, Trailer Cable, Car Speaker Wire, Fusible Link Wire) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Motor Vehicle And Parts Dealers Global Market Report 2024 – By Type (Auto Parts And Accessories, Automobile Dealers, Other Motor Vehicle Dealers), By Ownership (Retail Chain, Independent Retailer), By Type of Store (Exclusive Retailers or Showroom, Inclusive Retailers or Dealer Store) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Automobiles And Heavy Equipment Global Market Report 2024 – By Type (Business Services, Managed Services, System Integrator, Other Types), By Size (Heavy Trucks, Medium Trucks, Light Trucks), By Application (Cars And Light Trucks, Medium And Heavy Trucks, Farm And Construction Equipment, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Electric Motor And Generator Global Market Report 2024 – By Type (Electric Motors, Electric Generators), By Application (Industrial Machinery, Automobile (Motor Vehicle), HVAC (Heating, Ventilation, And Air Conditioning), Other Applications), By End User (Industrial, Residential, Commercial) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the carbapenem-based antibiotics market?

Carbapenem-based antibiotics are a class of broad-spectrum antibiotics that are highly effective against many bacterial infections. Carbapenem antibiotics are commonly used to treat severe infections caused by gram-positive and gram-negative bacteria, including some strains resistant to other antibiotics. For further insights on the carbapenem-based antibiotics market, request a sample here

How will the carbapenem-based antibiotics market drivers and restraints affect the carbapenem-based antibiotics market dynamics? What forces will shape the carbapenem-based antibiotics industry going forward?

The carbapenem-based antibiotics market major growth driver - Rising Bacterial Infections And The Surge In Demand For Carbapenem-Based Antibiotics Is A Driving Force In Market Expansion. For further insights on the carbapenem-based antibiotics market, request a sample here

What is the forecast market size or the forecast market value of the carbapenem-based antibiotics market?

The carbapenem-based antibiotics market size has grown strongly in recent years. It will grow from $4.43 billion in 2023 to $4.66 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epidemics and pandemics, rise in chronic diseases, healthcare infrastructure growth, rapid urbanization, natural disasters and health emergencies.. The carbapenem-based antibiotics market size is expected to see strong growth in the next few years. It will grow to $5.71 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increased incidence of hospital-acquired infections, emergence of multi-drug resistant strains, growing aging population, rise in surgical procedures, proliferation of infectious diseases, changing demographics.. Major trends in the forecast period include supply chain resilience and security, alternative treatment development, shift towards outpatient settings, growing awareness on antimicrobial stewardship, precision medicine approaches.. For further insights on the carbapenem-based antibiotics market, request a sample here

How is the carbapenem-based antibiotics market segmented?

The carbapenem-based antibiotics market is segmented
1) By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types
2) By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin and Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online PharmaciesFor further insights on the carbapenem-based antibiotics market, request a sample here

Which region has the largest share of the carbapenem-based antibiotics market? What are the other regions covered in the report?

North America was the largest region in the Carbapenem-Based Antibiotics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the carbapenem-based antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the carbapenem-based antibiotics market, request a sample here.

Who are the major players in the carbapenem-based antibiotics market?

Major companies operating in the carbapenem-based antibiotics market report are Pfizer Inc., Merck & Co. Inc., Saint-Gobain S.A., Fresenius Kabi LLC, GlaxoSmithKline Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Meiji Holdings Co. Ltd., Sandoz International GmbH, Sumitomo Dainippon Pharma Co. Ltd., Shionogi & Co Ltd., Aurobindo Pharma Ltd., Acurx Pharmaceuticals LLC, Daewoong Pharmaceutical Co. Ltd., CeramTec GmbH, ACS Dobfar S.p.A, JW Pharmaceutical Corp, Centrient Pharmaceuticals Co, Spero Therapeutics Inc., Kopran Limited, Savior Lifetec Corporation, Amedica Corporation, Flagship Biotech International Pvt. Ltd., Iterum Therapeutics plc, Cam Carbapenem-based antibiotics BV, Intelicure Lifesciences, Ikeda Corporation For further insights on the carbapenem-based antibiotics market, request a sample here.

What are the key trends in the carbapenem-based antibiotics market?

Major trend in the carbapenem-based antibiotics market - Innovative Product Launches Drive Growth In The Carbapenem-Based Antibiotics Market. For further insights on the carbapenem-based antibiotics market, request a sample here.

What are the major opportunities in the carbapenem-based antibiotics market? What are the strategies for the carbapenem-based antibiotics market?

For detailed insights on the major opportunities and strategies in the carbapenem-based antibiotics market, request a sample here.

How does the carbapenem-based antibiotics market relate to the overall economy and other similar markets?

For detailed insights on carbapenem-based antibiotics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the carbapenem-based antibiotics industry?

For detailed insights on the mergers and acquisitions in the carbapenem-based antibiotics industry, request a sample here.

What are the key dynamics influencing the carbapenem-based antibiotics market growth? SWOT analysis of the carbapenem-based antibiotics market.

For detailed insights on the key dynamics influencing the carbapenem-based antibiotics market growth and SWOT analysis of the carbapenem-based antibiotics industry, request a sample here.